Drug Profile
KUR 1247
Latest Information Update: 12 Oct 2006
Price :
$50
*
At a glance
- Originator Kissei Pharmaceutical
- Class
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Preterm labour
Most Recent Events
- 12 Oct 2006 Discontinued - Preclinical for Preterm labour in Japan (unspecified route)
- 26 May 2001 No-Development-Reported for Preterm labour in Japan (Unknown route)
- 12 Jun 1998 Preclinical development for Preterm labour in Japan (Unknown route)